Androgen-dependent gene expression is also decreased in human prostate cancers with PTEN loss alone (compared to tumors without PTEN loss) but is partially restored in tumors with combined PTEN and FOXP1 loss (Fig. 3d, Supplementary Fig. 6c). Here, PTEN is linked to prostate carcinoma.